Form 4: Prestige Consumer Healthcare Insider Transaction Report
Statement of Changes in Beneficial Ownership
Senior VP of Operations Jeffrey Zerillo reported the vesting of performance stock units and subsequent sale of shares.
Summary
- Jeffrey Zerillo, Senior VP of Operations at Prestige Consumer Healthcare, reported the vesting of 2,450 performance stock units (PSUs) on May 4, 2026.
- A total of 1,243 shares were withheld to cover tax obligations at a price of $55.31 per share.
- The reporting person was granted 2,857 restricted stock units (RSUs) vesting in three installments through 2029.
- A sale of 346 shares was executed on May 5, 2026, at a price of $55.32 per share.
- Following these transactions, the reporting person holds 44,334 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard executive compensation and tax management.
Positives
- Successful vesting of performance-based equity indicates achievement of internal growth goals.
- Continued alignment of management interests with shareholders through ongoing RSU grants.
Negatives
- Minor sale of shares by a senior executive, though this appears to be routine or tax-related.
Risks
- Reliance on performance-based equity targets which may not be met in future periods.
Future Outlook
The reporting person received 2,857 restricted stock units that will vest in three equal installments on May 4, 2027, May 4, 2028, and May 4, 2029.
Management Comments
- Transactions were made pursuant to a Rule 10b5-1(c) trading plan.
Industry Context
StockSavvy.ai notes that routine equity vesting and tax-related share sales by executives are standard corporate governance practices in the consumer healthcare sector and generally do not signal a change in company strategy.
Comparison to Industry Standards
- The use of performance-based equity vesting is consistent with compensation structures at peer consumer goods companies like Church & Dwight or Perrigo.
Stakeholder Impact
- Minimal impact on shareholders as transactions are related to standard executive compensation plans.
Next Steps
- Vesting of RSU installments scheduled for May 2027, 2028, and 2029.
Key Dates
| Date | Description |
|---|---|
| 05/05/2023 | Original grant date of performance stock units. |
| 05/04/2026 | Vesting date of performance stock units and transaction date for share withholding. |
| 05/05/2026 | Date of open market sale of shares. |
| 05/06/2026 | Filing date of the Form 4. |
Keywords
Prestige Consumer Healthcare, PBH, Insider Trading, Form 4, Equity Compensation, Stock Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.